Peter Hölscher

Title: Peter Hölscher: Innovator in Pharmaceutical Chemistry

Introduction

Peter Hölscher is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that serve as nitric oxide synthase (NOS) inhibitors. With a total of 2 patents to his name, his work has implications for the treatment of various medical conditions.

Latest Patents

Hölscher's latest patents include innovative compounds that have garnered attention in the medical community. One of his patents focuses on "Fluorinated 3,4-dihydroquinoline derivatives used as NOS inhibitors." This invention relates to specific compounds and outlines a method for their production, emphasizing their potential use in medicaments. Another significant patent is for "Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals." This patent describes compounds that exhibit activity as NOS inhibitors, along with methods for their preparation and application in pharmaceuticals.

Career Highlights

Peter Hölscher is associated with Schering Aktiengesellschaft, a prominent company in the pharmaceutical industry. His work at this organization has allowed him to explore and develop innovative solutions that address critical health issues. His research has contributed to the advancement of therapeutic options available in the market.

Collaborations

Hölscher has collaborated with esteemed colleagues such as Hartmut Rehwinkel and Stefan Jaroch. These partnerships have fostered a collaborative environment that enhances the research and development process, leading to groundbreaking discoveries in pharmaceutical chemistry.

Conclusion

Peter Hölscher's contributions to the field of pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments, showcasing the importance of innovation in healthcare.